ACH vs INNV
ACH: Accendra Health delivers home healthcare equipment and medical supplies through Apria and Byram Healthcare brands, though the company faces severe financial headwinds including 75% revenue decline, negative profitability, and substantial debt relative to market value. INNV: InnovAge operates integrated primary care and chronic disease management centers under the PACE model for frail elderly populations, earning capitated fees from government payors.
Side-by-side fundamentals
| Metric | ACH | INNV | Edge |
|---|---|---|---|
| Price as of 2026-07-22 close | $3.16 | $11.68 | |
| Market cap as of 2026-07-23 | $255M | $1.6B | |
| PEG as of 2026-07-23 | -0.00 | n/a | |
| Net margin as of 2026-07-23 | -39.8% | -1.2% | INNV higher |
| Gross margin as of 2026-07-23 | +46.0% | +21.8% | ACH higher |
| Operating margin as of 2026-07-23 | +0.9% | -1.0% | ACH higher |
| ROE as of 2026-07-23 | -50.9% | -4.8% | INNV higher |
| ROA as of 2026-07-23 | -33.1% | -2.2% | INNV higher |
| Debt / equity as of 2026-07-23 | 3.41 | 0.30 | INNV lower |
| Revenue growth (YoY) as of 2026-07-23 | -74.7% | +14.1% | INNV higher |
| Revenue CAGR (3y) SEC XBRL | -34.8% | +6.9% | INNV higher |
| Dividend streak (yrs) SEC XBRL | 3 | n/a | |
| Beta as of 2026-07-23 | 1.59 | 0.38 | |
| 1-year return as of 2026-07-22 close | -55.8% | +211.6% | INNV higher |
Fundamentals: Finnhub, as of 2026-07-23. Filings: SEC EDGAR. Prices are delayed daily-close data.
Last updated 2026-07-22.
Informational only — NOT financial advice. All figures are delayed daily-close data from SEC EDGAR & Finnhub, shown with their as-of date; "Edge" cells are a pure numeric comparison, not a recommendation.